Principal Pharmacometric Scientist — PK/PD & MIDD

Able Too Work; Antwerpen; Hybrid; EUR 80,000 - 138,000; Full time

Benefits offered by this job

Annual bonus

Vacation days

Parental leave

Bereavement leave

Well-being reimbursement

Employee benefits program

Job summary

Johnson & Johnson seeks a Principal Scientist Pharmacometrics to lead population PK/PD/ER modeling for compounds in development. You will author pharmacometrics documents for regulatory submissions and support agency inquiries with senior scientists.

Guided by group leadership, you will support Model Informed Drug Development plans and execute day‑to‑day pharmacometric analyses, contributing to regulatory meetings and strategic decisions. Travel ~5% may be required.

Qualifications

• Ph.D. in relevant field with 2+ years post-doctoral experience or MS with 4+ years of relevant experience.
• Extensive PK/PD modeling and pharmacometrics experience using standard tools.
• Understanding of drug development and MIDD concepts and regulatory guidance.
• Excellent oral and written communication skills.

Responsibilities

• Lead population PK/PD/ER analyses to guide dose and development decisions.
• Prepare analysis plans and reports; define data needs and QC checks.
• Collaborate in a matrix organization to manage pharmacometrics deliverables and timelines.
• Develop new methods and applications in pharmacometrics.

Skills

Pharmacokinetics

Pharmacology

Pharmacometrics

Program Management

Report Writing

Critical Thinking

Drug Development

Drug Discovery Development

Organizing

Researching

Scientific Research

Education

Ph.D. in Pharmaceutical Sciences/Pharmacometrics/Bioengineering or Biological Sciences

Tools

NONMEM

Monolix

R

Job description

Johnson & Johnson seeks a Principal Scientist Pharmacometrics to lead population PK/PD/ER modeling for compounds in development. You will author pharmacometrics documents for regulatory submissions and support agency inquiries with senior scientists.

Guided by group leadership, you will support Model Informed Drug Development plans and execute day‑to‑day pharmacometric analyses, contributing to regulatory meetings and strategic decisions. Travel ~5% may be required.